How does AMBEY's PE Ratio compare to its peers?

AMBEY is expensive based on its Price-To-Earnings Ratio (34.2x) compared to the peer average (19.6x).

How does AMBEY's PE Ratio compare vs other companies in the IN Chemicals Industry?

AMBEY is expensive based on its Price-To-Earnings Ratio (34.2x) compared to the Indian Chemicals industry average (31.4x).

What is AMBEY's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate AMBEY's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of AMBEY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate AMBEY's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Ambey Laboratories (NSEI:AMBEY) - Stock Price, News & Analysis

AMBEY Stock Overview

Engages in manufacturing and selling of agro chemicals, compounds, and related pharmaceutical products in India. More details

AMBEY fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	1/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap (₹2B)

Profit margins (3.6%) are lower than last year (5.7%)

Ambey Laboratories Limited Competitors

Basant Agro Tech (India)

BSE:524687

₹1.7b

Sikko Industries

NSEI:SIKKO

₹1.6b

Aristo Bio-Tech and Lifescience

NSEI:ARISTO

₹1.0b

Crop Life Science

NSEI:CLSL

₹785.9m

Price History & Performance

Summary of all time highs, changes and price drops for Ambey Laboratories
Historical stock prices
Current Share Price	₹64.55
52 Week High	₹97.20
52 Week Low	₹56.10
Beta	0
11 Month Change	8.31%
3 Month Change	-20.41%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-27.68%

Recent updates

Shareholder Returns

	AMBEY	IN Chemicals	IN Market
7D	5.4%	-0.8%	0.5%
1Y	n/a	10.7%	27.5%

Return vs Industry: Insufficient data to determine how AMBEY performed against the Indian Chemicals industry.

Return vs Market: Insufficient data to determine how AMBEY performed against the Indian Market.

Price Volatility

Is AMBEY's price volatile compared to industry and market?
AMBEY volatility
AMBEY Average Weekly Movement	6.3%
Chemicals Industry Average Movement	5.6%
Market Average Movement	6.1%
10% most volatile stocks in IN Market	9.1%
10% least volatile stocks in IN Market	4.0%

Stable Share Price: AMBEY has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine AMBEY's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1985	n/a	Archit Gupta	ambeylab.com

Ambey Laboratories Limited engages in manufacturing and selling of agro chemicals, compounds, and related pharmaceutical products in India. The company offers amine salt, sodium salt, and hexaconazole, as well as acid tech, ethyl ester tech, and ethylhexyl ester tech products. It also exports its products.

Ambey Laboratories Limited Fundamentals Summary

How do Ambey Laboratories's earnings and revenue compare to its market cap?
AMBEY fundamental statistics
Market cap	₹1.61b
Earnings (TTM)	₹47.11m
Revenue (TTM)	₹1.30b

34.2x

P/E Ratio

1.2x

P/S Ratio

Is AMBEY overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMBEY income statement (TTM)
Revenue	₹1.30b
Cost of Revenue	₹1.13b
Gross Profit	₹171.84m
Other Expenses	₹124.73m
Earnings	₹47.11m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.89
Gross Margin	13.24%
Net Profit Margin	3.63%
Debt/Equity Ratio	37.6%

How did AMBEY perform over the long term?

See historical performance and comparison

Ambey Laboratories NSEI:AMBEY Stock Report